Daré Bioscience to Present at Stifel’s 2026 Healthcare Conference
Daré Bioscience (NASDAQ: DARE) is scheduled to present at Stifel’s 2026 Healthcare Conference on November 11, 2026, in New York.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Daré Bioscience (NASDAQ: DARE) is scheduled to present at Stifel’s 2026 Healthcare Conference on November 11, 2026, in New York. Founder, President and Chief Executive Officer Sabrina Martucci Johnson will speak from 11:20 a.m. to 11:50 a.m. ET at the Lotte New York Palace Hotel.
The presentation will cover the company’s women’s health portfolio, commercial strategy and clinical pipeline. A live webcast will be publicly accessible, with a replay available through the company’s investor website for 90 days.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women's health between promising science and real-world solutions, today announced that Sabrina Martucci Johnson, Founder, President and Chief Executive Officer of Daré Bioscience, is scheduled to present at Stifel’s 2026 Healthcare Conference happening November 10 – 12, 2026 in New York, New York.
Presentation Details
- Presenter: Sabrina Martucci Johnson, Founder, President and Chief Executive Officer
- Date: Wednesday, November 11, 2026
- Time: 11:20 a.m.–11:50 a.m. ET
- Location: Lotte New York Palace Hotel, 5th Floor – Hubbard
- Live Webcast: Access here
During the presentation, Ms. Johnson will discuss Daré Bioscience’s women’s health portfolio, commercial strategy and clinical pipeline, including the Company’s progress in advancing innovative solutions to address unmet needs in women’s health. Ms. Johnson’s presentation will be webcast live and publicly accessible via the link provided above.
Following the Company’s presentation, a webcast replay will be made available for on-demand viewing and can be accessed through the Presentations, Events & Webcasts page of the Investors section of the Company’s website (darebioscience.com). The presentation will be accessible for 90 days.
ABOUT DARÉ BIOSCIENCE, INC.
Daré Bioscience (NASDAQ: DARE) is a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world solutions. Every innovation Daré Bioscience advances is based in advanced science and backed by rigorous, peer-reviewed research. From contraception to menopause, sexual health to fertility, vaginal health to infectious disease, Daré Bioscience is working to close critical gaps in care using science that serves her needs. For decades, women have been told to “wait it out” or “live with it,” while innovations that could improve their quality of life languish in the regulatory or funding pipeline. With growing awareness around menopause, sexual health, and vaginal health, the conversation is shifting. However, access to proven solutions is lagging. Daré Bioscience is working to change that. Learn more at darebioscience.com.
Contact:
Daré Bioscience Investor Relations
innovations@darebioscience.com
Source: Daré Bioscience, Inc.
